Government Says AI Can't Be an Inventor: Humans Only Rule Stands
Published Date: 11/28/2025
Notice
Summary
The USPTO updated its rules on who counts as an inventor when AI helps create inventions. They made it clear that only real people—not AI—can be inventors, and the same rules apply whether AI is involved or not. This change affects inventors and patent applicants starting now, so everyone should follow the usual inventorship rules to avoid delays or extra costs.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
Only Natural Persons Are Inventors
The USPTO says only natural persons — not AI systems — may be named as inventors on patent applications or issued patents. The office directs examiners to reject any application that lists an AI system or other non-natural person as an inventor or joint inventor under 35 U.S.C. 101 and 115.
Priority Claims Must Name Humans
If you claim benefit or priority to a prior U.S. or foreign application under 35 U.S.C. 119, 120, 121, 365, or 386, the U.S. application must name the same natural person(s) or have at least one natural person inventor in common. A priority claim to a foreign application that names an AI tool as the sole inventor will not be accepted by the USPTO.
Same Inventorship Standard Applies
The USPTO says the usual legal standard for inventorship applies to inventions made with AI assistance; there is no separate standard for AI-assisted inventions. The guidance cites 35 U.S.C. 115(b)(2) and centers inventorship on the human inventor's "conception" as defined by Federal Circuit case law.
Guidance Also Covers Design and Plant Patents
The USPTO says this inventorship guidance applies to utility, design, and plant patent applications and patents. For plant patents, the inventor must have contributed to creating the plant and asexually reproduced it, including when AI was used in development.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16744, Request for Comments on Community Outreach Office Locations in the Southwest States
The USPTO wants your ideas on where to open new community outreach offices in the Southwest states like Arizona and Texas. These offices will help inventors, small businesses, and students get better support with patents. Share your thoughts by September 16, 2026, so the USPTO can pick the best spots and keep innovation booming without extra costs to you!
2026-16315, Administrative Updates to the General Requirements Bulletin for Admission to the Examination for Registration To Practice in Patent Cases Before the United States Patent and Trademark Office
Starting August 11, 2026, the USPTO is upgrading Biomedical Science degrees from Category B to Category A for patent bar eligibility. This means more people with this degree can now take the patent exam and become patent practitioners. No extra fees or delays—just a smoother path for those with the right science background to join the patent world!
2026-14941, Grant of Interim Extension of the Term of U.S. Patent No. 8,461,196; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means they keep exclusive rights to the drug until July 25, 2027, giving them more time to sell it without competition. This extension helps the company protect their investment while the drug gets final approval.
2026-14939, Grant of Interim Extension of the Term of U.S. Patent No. 8,877,798; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means their patent, which was set to expire on July 25, 2026, now lasts until July 25, 2027. This extension helps Otsuka keep exclusive rights to their drug a bit longer while waiting for final FDA approval.
2026-14793, Requirement To Identify All Real Parties in Interest to a Third Party Request for an Ex Parte Reexamination
The USPTO wants anyone asking for a third-party ex parte reexamination to clearly say who’s really behind the request. This helps stop sneaky tricks and keeps the process honest. If you’re involved, get ready to share this info confidentially by August 21, 2026, or risk delays or issues.
2026-14388, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Admission to Practice and Roster of Registered Patent Attorneys and Agents Admitted to Practice Before the United States Patent and Trademark Office
The USPTO is asking for public feedback on its paperwork rules for patent attorneys and agents who want to practice before the office. This helps keep the process smooth and fair without making people fill out too many forms. If you have thoughts, send them in by August 17, 2026—no fees or big changes are happening right now, just a review.
Previous / Next Documents
Previous: 2025-21454, Notice of Proposed Reinstatement of BLM New Mexico Terminated Oil and Gas Leases: NMNM 141402
Tascosa Energy Partners wants their New Mexico oil and gas lease NMNM 141402 back after it was ended. The Bureau of Land Management agrees to reinstate it starting January 1, 2022, with new rules: $20 per acre rent and a 16.67% royalty. This means Tascosa can keep drilling, but with updated costs and terms.
Next: 2025-21459, Petition for Exemption; Summary of Petition Received; Rotor Technologies, Inc.
Rotor Technologies, Inc. asked the FAA for a special exemption from some aviation rules to help their business run smoother. This affects pilots and companies using Rotor’s tech, possibly speeding up operations without extra costs. The public can share their thoughts by December 29, 2025, so don’t miss your chance to weigh in!